Sir, – I am writing regarding the article entitled, “Ireland on the brink of eliminating hepatitis C” (October 29th) . A letter to the editor is ideally not the place to challenge the misleading ...
Boehringer Ingelheim has completed recruitment for a late-stage clinical trial programme for BI 201335, its oral protease inhibitor for the treatment of chronic hepatitis C virus. Boehringer Ingelheim ...
Achillion’s development of its hepatitis C treatment sovaprevir will be delayed after reports of abnormal liver functions in some patients caused regulators to suspend its clinical trial programme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback